Fred Lee
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Prostate Cancer Diagnosis and Treatment 18
- Prostate Cancer Treatment and Research 10
- Co-authors
- Duke Bahn (6 shared papers)Robert A. Badalament (5 shared papers)D B Siders (6 shared papers)Anil Kumar (1 shared paper)Michael R. Chernick (1 shared paper)Douglas O. Chinn (2 shared papers)Deirdre R. Meldrum (7 shared papers)Fengyu Su (7 shared papers)
- Journals
- Urology (5 papers)Cancer (3 papers)Journal of Endourology (2 papers)SAE technical papers on CD-ROM/SAE technical paper series (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Fred Lee
65 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 837
- Hepatology 192
- Urology 147
- Virology 106
- Rheumatology 313
Countries citing papers authored by Fred Lee
This map shows the geographic impact of Fred Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Lee more than expected).
Fields of papers citing papers by Fred Lee
This network shows the impact of papers produced by Fred Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Lee. The network helps show where Fred Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Fred Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 215 | |
| 2 | 2003 | 181 | |
| 3 | 2001 | 145 | |
| 4 | 2006 | 122 | |
| 5 | 2015 | 93 | |
| 6 | 1998 | 80 | |
| 7 | 2020 | 65 | |
| 8 | 2017 | 60 | |
| 9 | 2005 | 57 | |
| 10 | 1997 | 57 | |
| 11 | 1992 | 53 | |
| 12 | 1991 | 52 | |
| 13 | 2003 | 50 | |
| 14 | 1999 | 49 | |
| 15 | 2000 | 48 | |
| 16 | 2004 | 41 | |
| 17 | 2018 | 36 | |
| 18 | 1992 | 35 | |
| 19 | 1999 | 34 | |
| 20 | 2013 | 33 |
About Fred Lee
Fred Lee is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Rheumatology, Surgery and Oncology, having authored 66 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (18 papers), Urologic and reproductive health conditions (12 papers), Prostate Cancer Treatment and Research (10 papers), Analytical Chemistry and Sensors (6 papers), Electrochemical sensors and biosensors (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Esophageal and GI Pathology (4 papers) and Molecular Sensors and Ion Detection (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (837 citations), Hepatology (192 citations), Urology (147 citations), Virology (106 citations) and Rheumatology (313 citations). Fred Lee has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Duke Bahn, Robert A. Badalament, D B Siders, Anil Kumar, Michael R. Chernick, Douglas O. Chinn, Deirdre R. Meldrum, Fengyu Su, Yanqing Tian and Karin Rodland. Their work appears in journals such as Urology, Cancer, Journal of Endourology, SAE technical papers on CD-ROM/SAE technical paper series and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.